MetLife Investment Management’s Apogee Therapeutics APGE Stock Holding History

MetLife Investment Management’s Portfolio APGE Stock Details APGE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$764K	Hold
2025 Q2	$836K	Sell
2025 Q1	$845K	Sell
2024 Q4	$1.04M	Buy
2024 Q3	$1.24M	Buy
2024 Q2	$828K	Sell
2024 Q1	$1.41M	Buy
2023 Q4	$297K	Hold
2023 Q3	$227K	Buy